1. Home
  2. RNA vs PAY Comparison

RNA vs PAY Comparison

Compare RNA & PAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • PAY
  • Stock Information
  • Founded
  • RNA 2012
  • PAY 2004
  • Country
  • RNA United States
  • PAY United States
  • Employees
  • RNA N/A
  • PAY N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • PAY Computer Software: Prepackaged Software
  • Sector
  • RNA Health Care
  • PAY Technology
  • Exchange
  • RNA Nasdaq
  • PAY Nasdaq
  • Market Cap
  • RNA 4.4B
  • PAY 4.7B
  • IPO Year
  • RNA 2020
  • PAY 2021
  • Fundamental
  • Price
  • RNA $32.74
  • PAY $35.33
  • Analyst Decision
  • RNA Strong Buy
  • PAY Hold
  • Analyst Count
  • RNA 10
  • PAY 6
  • Target Price
  • RNA $63.60
  • PAY $28.80
  • AVG Volume (30 Days)
  • RNA 1.1M
  • PAY 450.0K
  • Earning Date
  • RNA 11-07-2024
  • PAY 11-12-2024
  • Dividend Yield
  • RNA N/A
  • PAY N/A
  • EPS Growth
  • RNA N/A
  • PAY 201.39
  • EPS
  • RNA N/A
  • PAY 0.32
  • Revenue
  • RNA $10,117,000.00
  • PAY $778,668,000.00
  • Revenue This Year
  • RNA N/A
  • PAY $37.66
  • Revenue Next Year
  • RNA N/A
  • PAY $22.59
  • P/E Ratio
  • RNA N/A
  • PAY $111.96
  • Revenue Growth
  • RNA N/A
  • PAY 33.82
  • 52 Week Low
  • RNA $8.37
  • PAY $14.77
  • 52 Week High
  • RNA $56.00
  • PAY $38.94
  • Technical
  • Relative Strength Index (RSI)
  • RNA 30.43
  • PAY 55.24
  • Support Level
  • RNA $32.04
  • PAY $31.64
  • Resistance Level
  • RNA $34.35
  • PAY $35.98
  • Average True Range (ATR)
  • RNA 2.07
  • PAY 1.61
  • MACD
  • RNA -0.55
  • PAY -0.53
  • Stochastic Oscillator
  • RNA 6.24
  • PAY 46.75

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.

About PAY Paymentus Holdings Inc.

Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers and financial institutions through a Software-as-a-Service, (SaaS), secure, omni-channel technology platform. The platform integrates into a biller's core financial and operating systems to provide flexible and secure access to payment processing of credit cards, debit cards, eChecks and digital wallets across a number of channels including online, mobile, IVR, call center, chatbot and voice-based assistants. The Company generates revenue from payment transaction fees processed through the Company's platform. The fees are generated as a percentage of transaction value or a specified fee per transaction.

Share on Social Networks: